Request Appointment
5 Columbus CircleNew York, NY 10019
Overview of Dr. Gukasyan
Dr. Natalie Gukasyan is a psychiatrist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and New York State Psychiatric Institute. She received her medical degree from Tulane University School of Medicine and has been in practice 1 year. She is one of 321 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 118 doctors at New York State Psychiatric Institute who specialize in Psychiatry. She has more than 20 publications and over 500 citings.
Education & Training
Center for Psychedelic and Consciousness Research, Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2019 - 2021
Johns Hopkins UniversityResidency, Psychiatry, 2015 - 2019
Tulane University School of MedicineClass of 2015- Cornell UniversityBS, Human Biology, Health, and Society, 2009
Certifications & Licensure
NJ State Medical License 2024 - 2027
NY State Medical License 2023 - 2026
MD State Medical License 2018 - 2024
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Effects of Psilocybin in Anorexia Nervosa Start of enrollment: 2019 Aug 26
Publications & Presentations
PubMed
- Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities: A Quantitative Survey Study.Rafaelle Lancelotta, Meghan DellaCrosse, Diana Quinn, Syre Saniyah, Micah Saniyah
Journal of Psychoactive Drugs. 2025-06-18 - 1 citationsA Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.David B Yaden, Marianna Graziosi, Alexa M Owen, Gabrielle Agin-Liebes, Scott T Aaronson
Psychedelic Medicine. 2025-03-01 - Ketamine and the Consequences of Positive Psychedelic Exceptionalism.Zachary J Verne, Natalie Gukasyan, Jeffrey Zabinski
The American Journal of Bioethics. 2025-01-01
Press Mentions
Shroom Compound Psilocybin Shows Promise for Bipolar Disorder in Early TrialDecember 6th, 2023- Illicit Drugs That Have Medicinal BenefitsJanuary 13th, 2023
- Psychedelic Therapy Is Moving to the Next Frontier: Workplace PerkDecember 6th, 2022
- Join now to see all
Professional Memberships
- Member
- College on Problems of Drug DependenceAssociate Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
